Logo image of FME.DE

FRESENIUS MEDICAL CARE AG (FME.DE) Stock Price, Quote, News and Overview

FRA:FME - Deutsche Boerse Ag - DE0005785802 - Common Stock - Currency: EUR

42.45  +0.36 (+0.86%)

FME.DE Quote, Performance and Key Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (4/24/2025, 5:36:15 PM)

42.45

+0.36 (+0.86%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High48.31
52 Week Low32.51
Market Cap24.91B
Shares586.83M
Float419.26M
Yearly Dividend1.19
Dividend Yield3.46%
PE13.06
Fwd PE11.46
Earnings (Next)05-06 2025-05-06
IPO10-02 1996-10-02


FME.DE short term performance overview.The bars show the price performance of FME.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

FME.DE long term performance overview.The bars show the price performance of FME.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20

The current stock price of FME.DE is 42.45 EUR. In the past month the price decreased by -6.5%. In the past year, price increased by 13.44%.

FRESENIUS MEDICAL CARE AG / FME Daily stock chart

FME.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CVS.DE CVS HEALTH CORP 12.12 72.66B
FRE.DE FRESENIUS SE & CO KGAA 13.24 22.45B
V3V.DE FAMICORD AG 29 71.62M

About FME.DE

Company Profile

FME logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 111,513 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Company Info

FRESENIUS MEDICAL CARE AG

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN DE

Employees: 113639

Company Website: https://www.freseniusmedicalcare.com/

Investor Relations: https://www.freseniusmedicalcare.com/en/investors/investors-overview/

Phone: 4961726090

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What is the stock price of FRESENIUS MEDICAL CARE AG today?

The current stock price of FME.DE is 42.45 EUR. The price increased by 0.86% in the last trading session.


What is the ticker symbol for FRESENIUS MEDICAL CARE AG stock?

The exchange symbol of FRESENIUS MEDICAL CARE AG is FME and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is FME.DE stock listed?

FME.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for FRESENIUS MEDICAL CARE AG stock?

26 analysts have analysed FME.DE and the average price target is 48.09 EUR. This implies a price increase of 13.28% is expected in the next year compared to the current price of 42.45. Check the FRESENIUS MEDICAL CARE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FRESENIUS MEDICAL CARE AG worth?

FRESENIUS MEDICAL CARE AG (FME.DE) has a market capitalization of 24.91B EUR. This makes FME.DE a Large Cap stock.


How many employees does FRESENIUS MEDICAL CARE AG have?

FRESENIUS MEDICAL CARE AG (FME.DE) currently has 113639 employees.


What are the support and resistance levels for FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a support level at 41.55 and a resistance level at 43.16. Check the full technical report for a detailed analysis of FME.DE support and resistance levels.


Is FRESENIUS MEDICAL CARE AG (FME.DE) expected to grow?

The Revenue of FRESENIUS MEDICAL CARE AG (FME.DE) is expected to grow by 4.49% in the next year. Check the estimates tab for more information on the FME.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FRESENIUS MEDICAL CARE AG (FME.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FRESENIUS MEDICAL CARE AG (FME.DE) stock pay dividends?

FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 3.46%. The yearly dividend amount is currently 1.19. Check the full fundamental report for a detailed analysis of FME.DE dividend history, reliability and sustainability.


When does FRESENIUS MEDICAL CARE AG (FME.DE) report earnings?

FRESENIUS MEDICAL CARE AG (FME.DE) will report earnings on 2025-05-06.


What is the Price/Earnings (PE) ratio of FRESENIUS MEDICAL CARE AG (FME.DE)?

The PE ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 13.06. This is based on the reported non-GAAP earnings per share of 3.25 and the current share price of 42.45 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FME.DE.


FME.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to FME.DE. When comparing the yearly performance of all stocks, FME.DE is one of the better performing stocks in the market, outperforming 70.03% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FME.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE. FME.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FME.DE Financial Highlights

Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 3.25. The EPS increased by 26.66% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.78%
ROA 1.6%
ROE 3.69%
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%3.41%
Sales Q2Q%1.94%
EPS 1Y (TTM)26.66%
Revenue 1Y (TTM)-0.61%

FME.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 66% to FME.DE. The Buy consensus is the average rating of analysts ratings from 26 analysts.

For the next year, analysts expect an EPS growth of 14.02% and a revenue growth 4.49% for FME.DE


Ownership
Inst Owners36.63%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts66.15
Price Target48.09 (13.29%)
EPS Next Y14.02%
Revenue Next Year4.49%